Varicella-zoster virus vaccine

Clinical Infectious Diseases

Volumn 24, Issue 5, 1997, Pages 753-763

  Jo White, C ^a  

^a North American Vaccine Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; CHICKENPOX VACCINE; DIPHTHERIA PERTUSSIS TETANUS HAEMOPHILUS INFLUENZAE TYPE B VACCINE; FAMCICLOVIR; FOSCARNET; HERPES ZOSTER IMMUNOGLOBULIN; MEASLES MUMPS RUBELLA VACCINE; ORAL POLIOMYELITIS VACCINE; OROVAX; PLACEBO; UNCLASSIFIED DRUG; URACIL ARABINOSIDE; VALACICLOVIR; VARICELLA ZOSTER VACCINE;

CEREBELLAR ATAXIA; CHICKENPOX; CLINICAL TRIAL; DRUG EFFICACY; DRUG SAFETY; FEVER; HERPES ZOSTER; HUMAN; IMMUNE RESPONSE; IMMUNIZATION; INJECTION PAIN; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RASH; REVIEW; SEROCONVERSION; SKIN INFECTION; VARICELLA ZOSTER VIRUS; VIRUS ENCEPHALITIS; VIRUS REACTIVATION;

EID: 20644439547     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinids/24.5.753     Document Type: Review

References (19)

1. Committee on Infectious Diseases, American Academy of Pediatrics. Recommendations for the use of live attenuated varicella vaccine. Pediatrics 1995;95:791-6.
2. Centers for Disease Control and Prevention. Prevention of varicella. MMWR Morb Mortal Wkly Rep 1996;45(RR-11):1-36.
3. Grose C. Variation on a theme by Fenner: the pathogenesis of chickenpox. Pediatrics 1981;68:735-7.
4. Fenner F. The pathogenesis of the acute exanthems: an interpretation based on experimental investigations with mousepox (infectious ectromelia of mice). Lancet 1948;2:915-20.
5. Steiner P. Zur inokulation der varicellen. Wein Med Wochenschr 1875; 25:306.
6. Weller TH, Stoddard MB. Intranuclear inclusion bodies in cultures of human tissue inoculated with varicella vesicle fluid. J Immunol 1952; 68:311-9.
7. Takahashi M, Okuno Y, Otsuka T, et al. Development of a live attenuated varicella vaccine. Biken J 1975;18:25-33.
8. Croen KD, Ostrove JM, Dragovic LJ, Straws SE. Patterns of gene expression and sites of latency in human nerve ganglia are different for varicella-zoster and herpes simplex viruses. Proc Natl Acad Sci USA 1988; 85:9773-7.
9. Simpson REH. Infectiousness of communicable diseases in the household (measles, chickenpox, and mumps). Lancet 1952;ii:549-54.
10. Ross AH. Modification of chicken pox in family contacts by administration of gamma globulin. N Engl J Med 1962;267:369-76.
11. van Loon F, Markowitz L, McQuillan G, et al. Varicella seroprevalence in U.S. population. In: Program and abstracts of the 33rd Interscience Conference on Antimicrobial Agents and Chemotherapy (New Orleans). Washington, DC: American Society for Microbiology, 1993.
12. Ooi PL, Goh KT, Doraisingham S, Ling AE. Prevalence of varicella-zoster virus infection in Singapore. Southeast Asian J Trop Med Public Health 1992;23:22-5.
13. Pastuszak AL, Levy M, Schick B, et al. Outcome after maternal varicella infection in the first 20 weeks of pregnancy. N Engl J Med 1994;330: 901-5.
14. Straus SE, Ostrove JM, Inchauspe G, et al. Varicella-zoster virus infections: biology, natural history, treatment, and prevention [NIH conference discussion]. Ann Intern Med 1988;108:221-37.
15. Preblud SR. Varicella: complications and costs. Pediatrics 1986; 78(4 part 2)(suppl):728-35.
16. Guess HA, Broughton DD, Melton LJ III, Kurland LT. Population-based studies of varicella complications. Pediatrics 1986; 78(4 part 2)(suppl): 723-7.
17. Preblud SR, Orentstein WA, Bart KJ. Varicella: clinical manifestations, epidemiology and health impact in children. Pediatr Infect Dis 1984;3: 505-9.
18. Baba K, Yabuuchi H, Takahashi M, Ogra PL. Increased incidence of herpes zoster in normal children infected with varicella zoster virus during infancy: community-based follow-up study. J Pediatr 1986;108: 372-7.
19. Guess HA, Broughton DD, Melton LJ III, Kurland LT. Epidemiology of herpes zoster in children and adolescents: a population-based study. Pediatrics 1985;76:512-7.